Brief: Bone Therapeutics To Raise Capital Through Private Placement Of New Shares And Issuance Of Non-Dilutive Subordinated Bonds

Biosenic SA

27/06/2019 06:05

June 27 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * BONE THERAPEUTICS SA TO RAISE CAPITAL THROUGH PRIVATE
PLACEMENT
OF NEW SHARES AND ISSUANCE OF NON-DILUTIVE SUBORDINATED BONDS
    * ANNOUNCES ITS INTENTION TO RAISE FUNDS FOR AN APPROXIMATE
AMOUNT
OF EUR 8.5 MILLION
    * PLACEMENT OF FULLY-SUBSCRIBED NON-DILUTIVE SUBORDINATED
BONDS (
"BOND ISSUANCE") FOR A TOTAL AGGREGATE AMOUNT OF EUR 3.5 MILLION
    * SUBORDINATED BONDS WILL BE ISSUED IN REGISTERED FORM,
REDEEMABLE
AT 100% OF THEIR PRINCIPAL AMOUNT WITH MATURITY OF 48 MONTHS AND
COUPON OF 8% PER ANNUM
    * INTENDS TO USE NET PROCEEDS TO INITIATE PHASE II/III
PROGRAMME
IN EU AND US WITH ALLOB, IN PATIENTS WITH DELAYED-UNION
FRACTURES
    * COUPON WILL BE PAYABLE ANNUALLY
    * TRADING OF SHARES OF COMPANY ON EURONEXT BRUSSELS AND
EURONEXT
PARIS WILL BE SUSPENDED DURING ACCELERATED BOOKBUILD OFFERING
    * INTENDS TO USE NET PROCEEDS TO FUND NON-CLINICAL
DEVELOPMENTS OF
ALLOB
    * TRADING IN SHARES IS EXPECTED TO RESUME FOLLOWING
PUBLICATION OF
RESULTS OF PRIVATE PLACEMENT
    * BELFIUS BANK NV/SA, IN COOPERATION WITH KEPLER CHEUVREUX
SA AND
ITS AFFILIATES, IS ACTING AS SOLE BOOKRUNNER IN PRIVATE
PLACEMENT
    * INTENDS TO USE NET PROCEEDS TO START PHASE III PROGRAMME
IN EU
AND US WITHJTA-004, IN PATIENTS WITH KNEE OSTEOARTHRITIS

Source text for Eikon:  ID:nGNE2pvqNL 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))